Bull vs Bear: GlaxoSmithKline
Investors' Chronicle - Un pódcast de Investors' Chronicle
Categorías:
GlaxoSmithKline (GSK) is a company that divides opinion and therefore an ideal candidate for the IC's Bull vs Bear series. In this episode, Simon Gergel from the Merchants Trust argues the bull case against the ICs pharma specialist (and GSK sceptic), Megan Boxall. Hosted on Acast. See acast.com/privacy for more information.
